JPRN-UMIN000021790未知未知
Efficacy and safety on effects of ribavirin with sofosbuir and ledipasvir combination therapy for patients who failed to daclatasvir and asunaprevir combination therapy - LDV/SOF+RBV combination therapy for patients with chronic hepatitis C who failed to DAC/ASV therapy
适应症
试验速览
- 阶段
- 未知
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) HBV or HIV co-infected patients 2) Patients with a hepatocellular carcinoma, at the start of treatment 3) Patients with pregnancy, or possibility to be pregnant, or on breast feeding 4) Patients with a history of hypersensitivity to other nucleoside-analogue 5) Patients with severe renal dysfunction or need to be treated on hemodialysis 6) Patients with poorly controlled cardiac disease (e.g., myocardial infarction, cardiac failure, arrhythmia) 7) Patients with abnormal hemoglobin disease 8) Patients with severe depression, suicidal ideation, or severe mental illness 9) Patients with severe hepatic impairment 10) Patients with Autoimmune hepatitis 11) Patients taking medicine as below: rifampicin, phenytoin, carbamazepine, seiyouotogisou-including foods 12) Patients who took investigational agents within 3 months prior to this study 13) Patients who are unsuitable for study entry in the opinion of the principal investigator, for this study due to any other reason
研究者
相似试验
招募中
不适用
Efficacy and safety of sofosbuvir and ribavirin in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000017703Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology500
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ribavirin for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019469Toranomon Hospital100
已完成
不适用
Efficacy of sofosbuvir and ribavirin therapy in patients with genotype 2 hepatitis C virus: Significance of variants associated with resistance in NS3, NS5A and NS5B regiothe patients infected with genotype 2 HCV who received combination therapy with sofosbvir and rivabirin.JPRN-UMIN000018089Department of Gastroenterology & Hepatology, Saitama Medical University40
已完成
不适用
An explosive study on add-on effects of ribavirin in sofosbuir and ledipasvir combination therapy for patients who failed to daclatasvir and asunaprevir combination therapy.Patients with chronic HCV infection, who failed to DCV/ASV therapyJPRN-UMIN000020009Hokkaido University Department of Gastroenterology and Hepatology, Graduate School of Medicine,15
已完成
不适用
Effects of Ribavirin and dexamethasone on clinical outcome of Crimean-Congo Hemorrhagic FeverCrimean-Congo Hemorrhagic Fever.Central Asian haemorrhagic feverIRCT2015120525378N1Vice chancellor for research,Zahedan University of Medical Sciences50